A1D5L
~{N}-(3-methoxy-5-methyl-pyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide
Find entries where: A1D5L
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
|---|---|
| Name | ~{N}-(3-methoxy-5-methyl-pyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide |
| Synonyms | Zibotentan |
| Identifiers | ~{N}-(3-methoxy-5-methyl-pyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide |
| Formula | C19 H16 N6 O4 S |
| Molecular Weight | 424.433 |
| Type | NON-POLYMER |
| Isomeric SMILES | Cc1cnc(c(n1)OC)NS(=O)(=O)c2cccnc2c3ccc(cc3)c4nnco4 |
| InChI | InChI=1S/C19H16N6O4S/c1-12-10-21-17(19(23-12)28-2)25-30(26,27)15-4-3-9-20-16(15)13-5-7-14(8-6-13)18-24-22-11-29-18/h3-11H,1-2H3,(H,21,25) |
| InChIKey | FJHHZXWJVIEFGJ-UHFFFAOYSA-N |
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 46 |
| Chiral Atom Count | 0 |
| Bond Count | 49 |
| Aromatic Bond Count | 23 |
Drug Info: DrugBank
| DrugBank ID | DB06629 |
|---|---|
| Name | Zibotentan |
| Groups | investigational |
| Synonyms | Zibotentan |
| Indication | Investigated for use/treatment in prostate cancer. |
| CAS number | 186497-07-4 |
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL1628688 |
| PubChem | 9910224 |
| ChEMBL | CHEMBL1628688 |
| ChEBI | CHEBI:94573 |
